What question did this study set out to answer?

The study aims to explore how PD-1 influences CD4 T cell differentiation and trafficking during hyperlipidemia and its implications for B cell responses.

July 30, 2026The Journal of Immunology

PD-1 regulates CD4 T cell differentiation and trafficking in response to hyperlipidemia in mice and humans 2260972

Q: What is the clinical evidence from this study?

Study design: Other. Population: Coronary artery disease and hyperlipidemia. Intervention: CD4-specific loss of PD-1 vs. Wild-type or baseline PD-1 expression. Primary outcome: CD4 T cell activation, differentiation, and trafficking markers.

View Full Paper

Ask AI

Bookmark

Key result

CD4-specific PD-1 loss boosts proatherogenic T cell activation and chemokine receptor expression in hyperlipidemia.

Population

CD4CreERT2Pdcd1fl/fl mice and a matched cohort of patients with low and high severity coronary artery disease

Comparison

CD4-specific inducible loss of PD-1 and PD-1… vs Control mice / comparison between low and high…

Design

Preclinical

Authors

SBSydney BlimbaumUniversity of Virginia HKHema KothariCarter Center KRKatherine RootCarter Center

Discussion

Member takes

Implication

PD-1 regulates CD4 T cell activation and trafficking to atherosclerotic lesions during hyperlipidemia, highlighting its role in atherosclerosis progression.

Key Points

The study aims to explore how PD-1 influences CD4 T cell differentiation and trafficking during hyperlipidemia and its implications for B cell responses.
Developed CD4-specific inducible loss of PD-1 using CD4CreERT2Pdcd1fl/fl mice.
Conducted a matched cohort analysis of patients with varying severity of coronary artery disease (CAD).
Performed CITE-Seq on PBMCs collected during coronary angiography imaging.
CD4-specific loss of PD-1 during hyperlipidemia leads to increased CD4 T cell activation and differentiation into Th subtypes, while naïve CD4 T cell frequency decreases.
Increased expression of CXCR3 and CCR5 in CD4 T cells correlates with enhanced trafficking to atherosclerotic lesions.
Significant changes in B cell surface markers indicate disturbances in T-dependent B cell activation without PD-1 signaling.

Structured PICO

Population

A matched cohort of patients with low and high severity CAD, alongside a murine model with CD4-specific inducible loss of PD-1.

Exposure

CD4-specific inducible loss of PD-1 (in mice) and PD-1 expression profiling (in humans)

Comparator

Control mice / comparison between low and high severity CAD

Outcome

CD4 T cell activation, differentiation, and trafficking markers (CXCR3, CCR5)surrogate

PD-1 regulates CD4 T cell activation and trafficking to atherosclerotic lesions during hyperlipidemia, highlighting its role in atherosclerosis progression.

Cite This Study

Blimbaum et al. (2026) studied Coronary artery disease and hyperlipidemia. CD4-specific loss of PD-1 vs. Wild-type or baseline PD-1 expression was evaluated on CD4 T cell activation, differentiation, and trafficking markers. CD4-specific loss of PD-1 during hyperlipidemia increased CD4 T cell activation and expression of trafficking markers CXCR3 and CCR5, which were also observed in PD-1+ CD4s from CAD patients.

synapsesocial.com/papers/6a6af50460e2b924d3ea097a https://doi.org/10.1093/jimmun/vkag141.1011

View Full Paper

Ask AI

Bookmark

Implication

PD-1 regulates CD4 T cell activation and trafficking to atherosclerotic lesions during hyperlipidemia, highlighting its role in atherosclerosis progression.

PD-1 regulates CD4 T cell differentiation and trafficking in response to hyperlipidemia in mice and humans 2260972

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

PD-1 regulates CD4 T cell differentiation and trafficking in response to hyperlipidemia in mice and humans 2260972

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Also Consider